Answers are grounded in this paper and cite their sources.
Discusses the clinical challenge of in-stent restenosis and the context for FDA approval of coronary-artery brachytherapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sapirstein et al. (2001) conducted an editorial in In-stent restenosis. Coronary-Artery Brachytherapy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: